Market Research

Psychedelic Invest is your source for the latest business and investing news about the burgeoning psychedelics industry.

How State-Level Psychedelic Policies Balance Safety and Access

Jul 30 • 7 min read

Psychedelic policies at the state level are evolving rapidly as more states move towards decriminalization. This transformation underscores the necessity for comprehensive discussions on how psychedelic sales can be managed effectively, ensuring safety and essential regulation while expanding access to their therapeutic benefits. The RAND Drug Policy Research Center recently published a report outlining various…

The Many Use Cases for Psilocybin-Assisted Therapy

Jul 25 • 5 min read

Psilocybin, a key compound in several species of hallucinogenic mushrooms, is at the forefront of the psychedelic renaissance. It has shown promise in treating various conditions such as anxiety, addiction, and depression. When ingested, psilocybin converts into psilocin, interacting with serotonin receptors in the brain. This interaction alters consciousness and can lead to significant mood…

Here’s How LSD Can Treat Depression

Jul 24 • 5 min read

Psychedelic drugs such as psilocybin mushrooms and LSD have long been recognized for their potential to address some of the world’s most widespread mental health disorders. These substances are not only effective in treating conditions like treatment-resistant depression and PTSD but also offer comfort to terminally ill patients experiencing end-of-life anxiety. However, until recently, the…

Psilocybin’s Impact on Brain Activity

Jul 23 • 3 min read

Psilocybin, the primary psychoactive compound found in hallucinogenic mushrooms, has long intrigued scientists and enthusiasts alike for its profound effects on perception and consciousness. Recent research conducted by the Washington University School of Medicine in St. Louis sheds new light on how this compound impacts the brain, offering promising insights into its potential therapeutic uses….

Therapeutic Potential of Psychedelics for Older Adults

Jul 22 • 3 min read

Psychedelics such as DMT, LSD, and psilocybin have shown significant potential in treating affective symptoms across a variety of disorders. These substances induce altered states of consciousness characterized by intensified perceptions and emotions, which are linked to therapeutic benefits. However, the inclusion of older individuals in psychedelic studies has been limited, leaving questions about the…

Pages: 1234567891011121314151617181920212223242526272829303132333435363738394041424344454647484950515253